Julian A. Symons's Net Worth
$5.52 Million
Who is Julian A. Symons?
Julian A. Symons has an estimated net worth of $5.52 Million. This is based on reported shares in Aligos Therapeutics, Inc..
SEC CIK
Julian A. Symons's CIK is 0001824727
Past Insider Trading and Trends
2024 was Julian A. Symons's most active year for acquiring shares with 5 total transactions. Julian A. Symons's most active month to acquire stocks was the month of January. 2020 was Julian A. Symons's most active year for disposing of shares, totalling 3 transactions. Julian A. Symons's most active month to dispose stocks was the month of January. 2020 saw Julian A. Symons paying a total of $0.00 for 218,517 shares, this is the most they've acquired in one year. In 2024 Julian A. Symons cashed out on 331,250 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aligos Therapeutics, Inc. (ALGS) Snapshot price: $14
See RemarksJulian A. Symons owns 394,064 units of Common Stock which is worth $5,516,896.00. From 2020 to 2024 Julian A. Symons acquired a total of 18,517 shares in Aligos Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27 - Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
| +4.93% | 18.52K |
—
|
—
| 394.06K |
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||